Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Regulation

EXCLUSIVE

What sector employers are doing to tackle rising violence against pharmacy staff

The CCA, AIMp and the NPA* are taking measures to ensure greater protection for pharmacists and pharmacy staff facing increased levels of violence at work, they have told C+D.

Businesses Crime

Healthcare provider told to meet pharmacy standards after missed medicine deliveries

Healthcare at Home, which delivers specialist medicines and provides nursing staff to administer them, has been told to improve after it failed to deliver medicines in time to thousands of patients, causing “a number of incidents where harm had occurred”.

Businesses Products

GPhC approves multi-year, flat rate pharmacist and pharmacy technician fees

The General Pharmaceutical Council (GPhC) will set pharmacy professionals’ registration fees for multiple years rather than reviewing them annually, it has announced after approving changes to its fees policy.

People GPhC

GPhC announces pass rate of 82% for July registration exam

The GPhC has announced a pass rate of 81.6% for its second online registration assessment, which candidates sat across three sittings on July 27, 28 and 29.

Pre-reg Registration exam
EXCLUSIVE

DH considering making both COVID and flu jabs mandatory for NHS staff

An upcoming consultation on whether to make the COVID-19 vaccine mandatory for all health and social care staff will also consider extending the requirement to flu vaccinations, the Department of Health and Social Care (DH) has told C+D. 

COVID-19 Elderly care

NPA urges competition watchdog to ‘look into’ hub-and-spoke dispensing

The NPA has called on the government’s competition watchdog to “look into” the hub-and-spoke dispensing model, to make sure it can exist without “undermining choice in the medicines supply chain and disadvantaging independent pharmacies”.

Regulatory bodies General Regulation

MHRA to pharmacies: Stop supplying specific batch of metformin oral solution

The Medicines and Healthcare products Regulatory Agency (MHRA) has asked pharmacies to “immediately” stop the supply of a specific batch of metformin oral solution, after a nitrosamine impurity was identified.

Diabetes General Regulation

Pregabalin removed from NI Formulary for neuropathic pain following rise in deaths

Pregabalin is no longer a “preferred option for the treatment of neuropathic pain” in new patients, following an increase in reported deaths involving the drug, community pharmacists and GPs in Northern Ireland (NI) have been told.

Pain Prescriptions
EXCLUSIVE

EMIS considers developing technology to support hub-and-spoke model

EMIS is considering implementing technology to support the hub-and-spoke dispensing model across community pharmacy, pending legislative changes, it has told C+D.

Businesses Digital

More than 400 PCR travel test providers, including some pharmacies, under CMA scrutiny

The Competition and Markets Authority (CMA) is to gather and analyse core information on more than 400 polymerase chain reaction (PCR) travel test providers, including some pharmacies, C+D understands.

Services Politicians
EXCLUSIVE

Little to no change in pharmacy professionals' experience of racism in 12 months, survey finds

The majority of respondents to C+D’s second annual racism in pharmacy survey have reported a lack of progress in tackling the issue, despite heightened awareness of racial inequality around the world.

People Businesses

MHRA recalls further 25 batches of contaminated irbesartan-containing medicines

The Medicines and Healthcare products Regulatory Agency (MHRA) has taken the "precautionary measure" of issuing a pharmacy/wholesaler level recall for a further 25 batches of irbesartan-containing medicines.

Manufacturers Products
See All
UsernamePublicRestriction

Register